Zhang Jiqin, Zhou Huanjiao Jenny, Ji Weidong, Min Wang
Center for Translational Medicine, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510080, China.
Curr Atheroscler Rep. 2015 May;17(5):503. doi: 10.1007/s11883-015-0503-z.
AIP1 (ASK1-interacting protein-1; encoded by the DAB2IP gene), a signaling scaffolding protein, is abundantly expressed in vascular endothelial cells (EC). While it was initially discovered as an apoptosis signal-regulating kinase 1 (ASK1)-interacting protein, AIP1 broadly suppresses inflammatory responses triggered by cytokines and stresses such as TNF, LPS, VEGF, and endoplasmic reticulum (ER) stress in EC (therefore, AIP1 is an anti-inflammatory protein). Human genome-wide association study (GWAS) has identified DAB2IP gene variants conferring susceptibility to cardiovascular diseases. Consistently, a global or vascular EC-specific deletion of DAB2IP in mice strongly enhances inflammatory responses and exacerbates atherosclerosis and graft arteriosclerosis progression in mouse models. Mechanisms for AIP1 function and regulation associated with human cardiovascular diseases need further investigations.
AIP1(ASK1相互作用蛋白-1;由DAB2IP基因编码)是一种信号支架蛋白,在血管内皮细胞(EC)中大量表达。虽然它最初被发现是一种与凋亡信号调节激酶1(ASK1)相互作用的蛋白,但AIP1广泛抑制EC中由细胞因子和应激(如TNF、LPS、VEGF和内质网(ER)应激)引发的炎症反应(因此,AIP1是一种抗炎蛋白)。人类全基因组关联研究(GWAS)已确定DAB2IP基因变异与心血管疾病易感性有关。同样,在小鼠中全局或血管EC特异性缺失DAB2IP会强烈增强炎症反应,并加剧小鼠模型中的动脉粥样硬化和移植动脉硬化进展。与人类心血管疾病相关的AIP1功能和调节机制需要进一步研究。